About the Books
Home > Books
Doctor, What if it Were Your Mother?
Dr. Victor Vogel is an oncologist who has been caring for women with breast cancer and doing clinical research in breast oncology for thirty years. He has sustained life-threatening and disabling illnesses. He has endured the death of his mother when he was a young oncologist and wrestled with the limits of medical care. A lifelong Christian, he has struggled with the challenges of answering questions about suffering and death for his patients, his family, and his friends. He is an ordained Presbyterian elder and a member of the board of directors of the Pittsburgh Theological Seminary. He has edited two medical textbooks, is the author of hundreds of professional articles and editorials, was a medical school professor for twenty-two years, and has traveled and lectured on four continents. He has appeared on national news broadcasts and has been quoted in the New York Times. He has been married for thirty-six years to a pediatrician, is the father of two children, and has two grandchildren.
Handbook of Breast Cancer Risk-Assessment
This essential little book provides on-the-spot clinical guidelines for assessing and advising patients on their risk of breast cancer, therapeutic options, and other issues of critical importance to women concerned about their breast health. In highly-condensed, outline format, the Handbook provides extensive, authoritative, and current recommendations on such critical issues as hormone replacement therapy, chemoprevention, lifestyle factors, genetic counseling, imaging of high-risk patients, economic factors, and much more.
Management of Patients at High Risk for Breast Cancer
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular genetic testing and other highly sophisticated diagnostic and prognostic techniques has made risk assessment and care a part of the work of many clinicians–from GPs to the super-specialist. Nowhere has the study of “prognostic factors” been more high-profile (and more clinically fruitful) than in breast cancer. Breakthroughs in the identification of genes associated with breast carcinoma, particularly BRCA1 and 2, as well as other risk factors, influence not only how patients are screened, but also how they are treated. With one in nine women likely to contract breast cancer in her lifetime, the significance of identifying and managing the high-risk patient is evident.